Form4insider filings, from the source

SEC Form 4 · accession 0001179110-16-030033

PTC THERAPEUTICS, INC. · PTCT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Sep 23, 2016
Accepted (ET)
Sep 26, 2016 · 4:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070081

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Sep 23, 2016M60,000$10.85A86,766D
Common StockF2holding———1,320,369ISee footnote

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F3$10.85Sep 23, 2016M60,000D—May 15, 2023Common Stock60,0000D
Stock Option (Right to Buy)F4$30.86holding————Jan 3, 2026Common Stock24,00024,000D
Stock Option (Right to Buy)$51.00holding———Jan 2, 2016Jan 1, 2025Common Stock24,00024,000D
Stock Option (Right to Buy)$27.05holding———Jan 28, 2015Jan 27, 2024Common Stock20,00020,000D
Stock Option (Right to Buy)F3$218.40holding————Jan 10, 2022Common Stock276276D
Stock Option (Right to Buy)F3$490.80holding————Apr 27, 2021Common Stock276276D
Stock Option (Right to Buy)F3$1,149.60holding————Feb 2, 2020Common Stock216216D
Stock Option (Right to Buy)F3$508.80holding————Oct 7, 2019Common Stock266266D
Stock Option (Right to Buy)F3$735.60holding————Jan 25, 2018Common Stock166166D
Stock Option (Right to Buy)F3$735.60holding————Jul 14, 2018Common Stock8383D
Stock Option (Right to Buy)F3$626.40holding————Apr 18, 2017Common Stock125125D

Explanation of responses